feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
LIDDS: First-patient-in for docetaxel Phase I
Research Note
2019-03-13
11:41
LIDDS today annonuced that their first patient has been enrolled in Phase I study with Nanozolid-docetaxl.
JS
MS
Jakob Svensson
Mathias Spinnars
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans